Clinical Trials

Edwards Lifesciences

IRB
Details
Info
EMC-IRB-24-021
The PROGRESS Trial - Continued Access Protocol
22-002
CLOSED TO ENROLLMENT: PROGRESS: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement (TAVR)